A phase II study of timed sequential therapy of acute myelogenous leukemia (AML) for patients over the age of 60: two cycle timed sequential therapy with topotecan, ara-C and mitoxantrone in adults with poor-risk AML
Javier Bolaños-Meade, Chuanfa Guo, Ivana Gojo, Judith E KarpVolume:
28
Year:
2004
Language:
english
Pages:
7
DOI:
10.1016/j.leukres.2003.10.026
File:
PDF, 96 KB
english, 2004